The fluorometric microculture cytotoxicity assay

被引:200
作者
Lindhagen, Elin [1 ]
Nygren, Peter [2 ]
Larsson, Rolf [1 ]
机构
[1] Uppsala Univ, Univ Uppsala Hosp, Div Clin Pharmacol, Dept Med Sci, SE-75185 Uppsala, Sweden
[2] Uppsala Univ, Univ Uppsala Hosp, Div Oncol, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden
关键词
D O I
10.1038/nprot.2008.114
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The fluorometric microculture cytotoxicity assay (FMCA) is a nonclonogenic microplate-based cell viability assay used for measurement of the cytotoxic and/or cytostatic effect of different compounds in vitro. The assay is based on hydrolysis of the probe, fluorescein diacetate (FDA) by esterases in cells with intact plasma membranes. The assay is available as both a semiautomated 96-well plate setup and a 384-well plate version fully adaptable to robotics. Experimental plates are prepared with a small amount of drug solution and can be stored frozen. Cells are seeded on the plates and cell viability is evaluated after 72 h. The protocol described here is applicable both for cell lines and freshly prepared tumor cells from patients and is suitable both for screening in drug development and as a basis for a predictive test for individualization of anticancer drug therapy.
引用
收藏
页码:1364 / 1369
页数:6
相关论文
共 18 条
[1]  
Blumenthal RD, 2005, METH MOLEC MED, V110, P3
[2]  
Bosanquet A, 2008, INNOVATIVE LEUKEMIA, V1st
[3]   CYTOTOXIC DRUG-SENSITIVITY TESTING OF TUMOR-CELLS FROM PATIENTS WITH OVARIAN-CARCINOMA USING THE FLUOROMETRIC MICROCULTURE CYTOTOXICITY ASSAY (FMCA) [J].
CSOKA, K ;
LARSSON, R ;
THOLANDER, B ;
GERDIN, E ;
DELATORRE, M ;
NYGREN, P .
GYNECOLOGIC ONCOLOGY, 1994, 54 (02) :163-170
[4]   Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance [J].
Dhar, S ;
Nygren, P ;
Csoka, K ;
Botling, J ;
Nilsson, K ;
Larsson, R .
BRITISH JOURNAL OF CANCER, 1996, 74 (06) :888-896
[5]   Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic [J].
Fridborg, H ;
Jonsson, E ;
Nygren, P ;
Larsson, R .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) :424-432
[6]  
FRIDBORG H, 1996, THESIS ACTA U UPSALI
[7]   Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model [J].
Fryknas, Marten ;
Rickardson, Linda ;
Wickstrom, Malin ;
Dhar, Sumeer ;
Lovborg, Henrik ;
Gullbo, Joachim ;
Nygren, Peter ;
Gustafsson, Mats G. ;
Isaksson, Anders ;
Larsson, Rolf .
JOURNAL OF BIOMOLECULAR SCREENING, 2006, 11 (05) :457-468
[8]   Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivity [J].
Hassan, S. B. ;
Haglund, C. ;
Aleskog, A. ;
Larsson, R. ;
Lindhagen, E. .
TOXICOLOGY IN VITRO, 2007, 21 (06) :1174-1181
[9]  
Hassan SB, 2001, J PHARMACOL EXP THER, V299, P1140
[10]  
Hjarnaa PJV, 1999, CANCER RES, V59, P5751